TLR4 and chronic kidney disease: Beyond these established pathways, UHR may influence CKD development through additional mechanisms, such as the upregulation of toll-like receptor 4 signaling, which amplifies inflammatory responses in renal tissues, or by promoting microvascular damage via the inhibition of nitric oxide bioavailability (41).